Nuvalent (NUVL) Shares Issued (2021 - 2026)
Nuvalent (NUVL) reported Shares Issued of $10.1 million for Q1 2026, up 122.55% on a YoY basis from $4.6 million in Q1 2025, and down 97.98% quarter-over-quarter from $500.6 million in Q4 2025.
Nuvalent (NUVL) Shares Issued (2021 - 2026) Analysis & Trends
Nuvalent has reported Shares Issued for 6 years, with the latest figure at $10.1 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued rose 122.55% year-over-year to $10.1 million; the trailing twelve-month figure through Mar 2026 stood at $521.3 million (down 6.52% YoY), and the FY2025 full-year result was $515.7 million, down 9.52% from the prior year.
- Shares Issued for Q1 2026 stood at $10.1 million, down from $500.6 million in the prior quarter.
- The five-year high for Shares Issued was $540.0 million in Q3 2024, with the low at $13000.0 in Q1 2022.
- Historically, Shares Issued has averaged $98.5 million across 5 years, with a median of $4.8 million in 2025.
- Annual changes were most pronounced in 2022 — Shares Issued slumped 99.78% — and 2024, when it soared 38804.9%.
- Nuvalent's Shares Issued stood at $249.9 million in 2022, then jumped by 34.0% to $334.8 million in 2023, then plunged by 97.38% to $8.8 million in 2024, then soared by 5597.51% to $500.6 million in 2025, then sank by 97.98% to $10.1 million in 2026.
- The last three Shares Issued figures came in at $10.1 million (Q1 2026), $500.6 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 26,927.15 |
| 10 | Nuvalent | 9.70 Bn | 9.70 Bn | - | 10.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.14 Mn |
| Mar 31, 2026 | 10.14 Mn |
| Dec 31, 2025 | 500.64 Mn |
| Dec 31, 2025 | 500.64 Mn |
| Sep 30, 2025 | 4.77 Mn |
| Sep 30, 2025 | 4.77 Mn |
| Jun 30, 2025 | 5.76 Mn |
| Jun 30, 2025 | 5.76 Mn |
| Mar 31, 2025 | 4.55 Mn |
| Mar 31, 2025 | 4.55 Mn |
| Dec 31, 2024 | 8.79 Mn |
| Dec 31, 2024 | 8.79 Mn |
| Sep 30, 2024 | 540.00 Mn |
| Sep 30, 2024 | 540.00 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 6.45 Mn |
| Mar 31, 2024 | 6.45 Mn |
| Dec 31, 2023 | 334.81 Mn |
| Dec 31, 2023 | 334.81 Mn |